What are the issues involved in using e-portfolios as a pedagogical tool?

A thesis submitted to the University of Bedfordshire, in partial fulfilment of the requirements for the degree of Doctor of PhilosophyIn Initial Teacher Training (ITT), one of the technologies rapidly being adopted to support the development of trainee teachers is the e-portfolio. Research into successful use of e-portfolios beyond their function as a repository has been scanty to date. The purpose of the current study was to extend the boundaries of understanding of e-portfolios beyond this function. This was undertaken through two in-depth case studies where e-portfolios were used as a pedagogical tool intended to support the development of reflective practice on a one year postgraduate ITT course, during two years of investigation in one university A mixed-methods approach was adopted to capture the richness of participants’ self reports of their experiences, statistical data regarding interactions on the e-portfolios and analysis of reflective writing. Data were collected and analysed from questionnaires, student and tutor interviews and interactions with the e-portfolio together with analysis of the content of reflective e-journals, with a special emphasis on the place and depth of reflection. What emerged was a rich contextual understanding of e-portfolio use by trainee teachers and tutors and the problematic nature of conceptualising and assessing reflective thinking, together with the extent to which the development and depth of their reflective thinking had been supported by e-portfolio use. The results confirm previous concerns related to the training requirements of users and also the time needed for students and tutors to engage in interactions. Further they imply that the prerequisites of successful use of e-portfolios, as a pedagogical tool, to support the development of reflective thinking include common agreement about what constitutes reflection and reflective thinking embedded within a strong, rigorous and well theorised conceptualisation of course structure and content. Implied also is the need for a well understood and transparent framework to assess the depth of reflective thinking that should complement the competencies that underpin Standards, and support the professional development of teachers

Silver nanoparticles in Zebrafish (Danio rerio) embryos: Uptake, growth and molecular responses

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Silver nanoparticles (AgNPs) are widely used in commercial applications as antimicrobial agents, but there have recently been increasing concerns raised about their possible environmental and health impacts. In this study, zebrafish embryos were exposed to two sizes of AgNP, 4 and 10 nm, through a continuous exposure from 4 to 96 h post‐fertilisation (hpf), to study their uptake, impact and molecular defense responses. Results showed that zebrafish embryos were significantly impacted by 72 hpf when continuously exposed to 4 nm AgNPs. At concentrations above 0.963 mg/L, significant in vivo uptake and delayed yolk sac absorption was evident; at 1.925 mg/L, significantly reduced body length was recorded compared to control embryos. Additionally, 4 nm AgNP treatment at the same concentration resulted in significantly upregulated hypoxia inducible factor 4 (HIF4) and peroxisomal membrane protein 2 (Pxmp2) mRNA expression in exposed embryos 96 hpf. In contrast, no significant differences in terms of larvae body length, yolk sac absorption or gene expression levels were observed following exposure to 10 nm AgNPs. These results demonstrated that S4 AgNPs are available for uptake, inducing developmental (measured as body length and yolk sac area) and transcriptional (specifically HIF4 and Pxmp2) perturbations in developing embryos. This study suggests the importance of particle size as one possible factor in determining the developmental toxicity of AgNPs in fish embryos

The Iowa Homemaker vol.4, no.2

Table of Contents To the High School Girls of Iowa by Anna E. Richardson, page 3 For the College Room by Barbara Mills Dewell, page 4 The Junior-Senior Banquet by Viola Jammer and Pauline Peacock, page 4 Picnic Preparations by Louise Evans Doole, page 5 Finding Yourself by H. M. Hamlin, page 6 Stories of the Sand by Katherine Holden, page 7 Appropriate Pictures for the Home by Amanda Jacobson, page 8 The Individual Scarf by Rhea Fern Schultz, page 9 Using Your Kodak by H. P. Doole, page 10 Something Plus by Laura E. Bublitz, page 11 The Ideal Homemaker by Rosalie Larson, page 12 University Life in France by Mercie Carley, page 12 Homemaker as Citizen by Jeanette Beyer, page 13 Who’s There and Where by Dryden Quist, page 14 Editorial, page 15 The Eternal Question, page 1

EACVI survey on investigations and imaging modalities in chronic coronary syndromes

AIMS The European Association of Cardiovascular Imaging (EACVI) Scientific Initiatives Committee performed a global survey to evaluate current practice for the assessment and management of patients with suspected and confirmed chronic coronary syndromes. METHODS AND RESULTS One-hundred and ten imaging centres from 37 countries across the world responded to the survey. Most non-invasive investigations for coronary artery disease were widely available, except cardiovascular magnetic resonance (available 40% centres). Coronary computed tomography angiography (CCTA) and nuclear scans were reported by a multi-disciplinary team in only a quarter of centres. In the initial assessment of patients presenting with chest pain, only 32% of respondents indicated that they rely on pre-test probability for selecting the optimal imaging test while 31% proceed directly to CCTA. In patients with established coronary artery disease and recurrent chest pain, respondents opted for stress echocardiography (27%) and nuclear stress perfusion scans (26%). In asymptomatic patients with coronary artery disease and an obstructive (>70%) right coronary artery stenosis, 58% of respondents were happy to pursue medical therapy without further testing or intervention. This proportion fell to 29% with left anterior descending artery stenosis and 1% with left main stem obstruction. In asymptomatic patients with evidence of moderate-to-severe myocardial ischaemia (15%), only 18% of respondents would continue medical therapy without further investigation. CONCLUSION Despite guidelines recommendations pre-test probability is used to assess patients with suspected coronary artery in a minority of centres, one-third of centres moving directly to CCTA. Clinicians remain reticent to pursue a strategy of optimal medical therapy without further investigation or intervention in patients with controlled symptoms but obstructive coronary artery stenoses or myocardial ischaemia

EACVI survey on investigations and imaging modalities in chronic coronary syndromes

Aims The European Association of Cardiovascular Imaging (EACVI) Scientific Initiatives Committee performed a global survey to evaluate current practice for the assessment and management of patients with suspected and confirmed chronic coronary syndromes.Methods and results One-hundred and ten imaging centres from 37 countries across the world responded to the survey. Most non-invasive investigations for coronary artery disease were widely available, except cardiovascular magnetic resonance (available 40% centres). Coronary computed tomography angiography (CCTA) and nuclear scans were reported by a multi-disciplinary team in only a quarter of centres. In the initial assessment of patients presenting with chest pain, only 32% of respondents indicated that they rely on pre-test probability for selecting the optimal imaging test while 31% proceed directly to CCTA. In patients with established coronary artery disease and recurrent chest pain, respondents opted for stress echocardiography (27%) and nuclear stress perfusion scans (26%). In asymptomatic patients with coronary artery disease and an obstructive (>70%) right coronary artery stenosis, 58% of respondents were happy to pursue medical therapy without further testing or intervention. This proportion fell to 29% with left anterior descending artery stenosis and 1% with left main stem obstruction. In asymptomatic patients with evidence of moderate-to-severe myocardial ischaemia (15%), only 18% of respondents would continue medical therapy without further investigation.Conclusion Despite guidelines recommendations pre-test probability is used to assess patients with suspected coronary artery in a minority of centres, one-third of centres moving directly to CCTA. Clinicians remain reticent to pursue a strategy of optimal medical therapy without further investigation or intervention in patients with controlled symptoms but obstructive coronary artery stenoses or myocardial ischaemia.</p

An outbreak of hantavirus pulmonary syndrome, Chile, 1997

Fil: Toro, Jorge. Ministry of Health; Chile.Fil: Vega, Jeanette D. Pan American Health Organization; Chile.Fil: Khan, Ali S. Centers for Disease Control and Prevention; Estados Unidos.Fil: Mills, James N. Centers for Disease Control and Prevention; Estados Unidos.Fil: Padula, Paula. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Terry, William. Centers for Disease Control and Prevention; Estados Unidos.Fil: Yadón, Zaida. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Valderrama, Rosa. Aysen Region XI Health Service; Chile.Fil: Ellis, Barbara A. Centers for Disease Control and Prevention; Estados Unidos.Fil: Pavletic, Carlos. Ministry of Health; Chile.Fil: Cerda, Rodrigo. Pan American Health Organization; Chile.Fil: Zaki, Sherif. Centers for Disease Control and Prevention; Estados Unidos.Fil: Wun-Ju, Shieh. Centers for Disease Control and Prevention; Estados Unidos.Fil: Meyer, Richard. Centers for Disease Control and Prevention; Estados Unidos.Fil: Tapia, Mauricio. Coyhaique Regional Hospital; Chile.Fil: Mansilla, Carlos. Coyhaique Regional Hospital; Chile.Fil: Baro, Michel. Llanchipal Health Services; Chile.Fil: Vergara, Jose A. Llanchipal Health Services; Chile.Fil: Concha, Marisol. Ministry of Health; Chile.Fil: Calderón, Gladys. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas Dr. Julio Maiztegui; Argentina.Fil: Enria, Delia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas Dr. Julio Maiztegui; Argentina.Fil: Peters, C.J. Centers for Disease Control and Prevention; Estados Unidos.Fil: Ksiazek, Thomas G. Centers for Disease Control and Prevention; Estados Unidos.An outbreak of 25 cases of Andes virus-associated hantavirus pulmonary syndrome (HPS) was recognized in southern Chile from July 1997 through January 1998. In addition to the HPS patients, three persons with mild hantaviral disease and one person with asymptomatic acute infection were identified. Epidemiologic studies suggested person-to-person transmission in two of three family clusters. Ecologic studies showed very high densities of several species of sigmodontine rodents in the area

An outbreak of hantavirus pulmonary syndrome, Chile, 1997

Fil: Toro, Jorge. Ministry of Health; Chile.Fil: Vega, Jeanette D. Pan American Health Organization; Chile.Fil: Khan, Ali S. Centers for Disease Control and Prevention; Estados Unidos.Fil: Mills, James N. Centers for Disease Control and Prevention; Estados Unidos.Fil: Padula, Paula. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Terry, William. Centers for Disease Control and Prevention; Estados Unidos.Fil: Yadón, Zaida. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Valderrama, Rosa. Aysen Region XI Health Service; Chile.Fil: Ellis, Barbara A. Centers for Disease Control and Prevention; Estados Unidos.Fil: Pavletic, Carlos. Ministry of Health; Chile.Fil: Cerda, Rodrigo. Pan American Health Organization; Chile.Fil: Zaki, Sherif. Centers for Disease Control and Prevention; Estados Unidos.Fil: Wun-Ju, Shieh. Centers for Disease Control and Prevention; Estados Unidos.Fil: Meyer, Richard. Centers for Disease Control and Prevention; Estados Unidos.Fil: Tapia, Mauricio. Coyhaique Regional Hospital; Chile.Fil: Mansilla, Carlos. Coyhaique Regional Hospital; Chile.Fil: Baro, Michel. Llanchipal Health Services; Chile.Fil: Vergara, Jose A. Llanchipal Health Services; Chile.Fil: Concha, Marisol. Ministry of Health; Chile.Fil: Calderón, Gladys. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas Dr. Julio Maiztegui; Argentina.Fil: Enria, Delia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas Dr. Julio Maiztegui; Argentina.Fil: Peters, C.J. Centers for Disease Control and Prevention; Estados Unidos.Fil: Ksiazek, Thomas G. Centers for Disease Control and Prevention; Estados Unidos.An outbreak of 25 cases of Andes virus-associated hantavirus pulmonary syndrome (HPS) was recognized in southern Chile from July 1997 through January 1998. In addition to the HPS patients, three persons with mild hantaviral disease and one person with asymptomatic acute infection were identified. Epidemiologic studies suggested person-to-person transmission in two of three family clusters. Ecologic studies showed very high densities of several species of sigmodontine rodents in the area

A Festschrift Recital: Celebrating Dr. Carol Kimball\u27s 36 Years at the University of Nevada, Las Vegas

Program listing performers and works performe